S. Eng

Inhibition of Hepatitis C Virus Replication by GS-6620, a Potent C-Nucleoside Monophosphate Prodrug

W. Zhong, M. Fenaux, K. Kitrinos, 2014, Antimicrobial Agents and Chemotherapy.

Preclinical Characterization of GS-9669, a Thumb Site II Inhibitor of the Hepatitis C Virus NS5B Polymerase

S. Leavitt, T. Appleby, M. Fenaux, 2012, Antimicrobial Agents and Chemotherapy.

Woolly Monkey–HBV Infection in Squirrel Monkeys as a Surrogate Nonhuman Primate Model of HBV Infection

R. Lanford, E. Salas, W. Delaney, 2020, Hepatology communications.

Inhibition of Hepatitis C Virus Replication by GS-6620 , A Potent C-Nucleoside 1 Monophosphate Prodrug 2 3 Running Title : In Vitro Pharmacology of GS-6620 4 5

W. Zhong, M. Fenaux, G. Cheng, 2014 .

Nucleotide Prodrug Containing a Nonproteinogenic Amino Acid To Improve Oral Delivery of a Hepatitis C Virus Treatment

Huiling Yang, M. Fenaux, Neeraj Tirunagari, 2018, Antimicrobial Agents and Chemotherapy.

Cell-Free Hepatitis B Virus Capsid Assembly Dependent on the Core Protein C-Terminal Domain and Regulated by Phosphorylation

W. Delaney, Jianming Hu, Kuancheng Liu, 2016, Journal of Virology.

1198 NUCLEOTIDE INHIBITOR RESISTANCE SELECTIONS USING GT2A INFECTIOUS VIRUS: PSI-7851 AND GS-6620 SELECT FOR A NOVEL RESISTANCE PATHWAY INCLUDING SUBSTITUTIONS OF M289V/L FOLLOWED BY S282T

Xiaohong Liu, W. Zhong, M. Fenaux, 2011 .